Hansruedi Juestrich acquires Similasan AG
HIGHLANDS RANCH, Colo. Similasan last week announced the acquisition of its Swiss-based parent company, Similasan AG, by Hansruedi Juestrich, owner of Nahrin AG, an international manufacturer and distributor of natural food products, food supplements and cosmetics.
“In the U.S., Similasan products are highly appreciated by consumers, and the brand has gained tremendous acceptance among our retail partners in the last decade,” stated Similasan chairman Michel Juestrich, son of Hansruedi. “We intend to continue building on past success and growing our brand via continued consumer marketing support and product launches.”
The new ownership plans no immediate changes to the U.S. business structure or brand strategy, the company stated.
“We are pleased to work with new ownership that understands our brand and our current go-to-market strategies,” stated Similasan’s U.S. vice president of sales, Dan Quail. “We continue to see a bright future for the Similasan group of companies both here and abroad.”
Natrol creates mini-show to introduce its health-focused products for the holidays
CHATSWORTH, Calif. If the holidays stress you out, then you maybe at risk weight gain as well as unhealthy mind. Natrol is trying to combat this with showcases of its products that can combat this problem of staying healthy over the holidays.
Natrol has created “The Balancing Act,” a four-minute segment produced by Five Star Productions and features Natrol products like: Carb Intercept, 5-HTP, Melatonin Time Release and My Favorite Multiple Original Multivitamin.
The segment, which aired on the Healthy Living Channel—on Comcast, Time Warner and Dish Network—on Thursday, Oct. 11, has been posted on Natrol’s web site, www.Natrol.com, as well as on Five Star’s website.
McNeil running ads on product withdrawal
FORT WASHINGTON, Pa. As part of its voluntary recall of several nonprescription products marketed toward infant use, McNeil Consumer Healthcare is today running an advertisement in several consumer daily newspapers.
“The cough-and-cold season is here, and we have important information to share about infants’ and children’s cough-and-cold medicines,” the ad starts, noting that while the medicines are generally recognized as safe and effective when used as directed, “we have become aware of rare instances of misuse leading to accidental overdose, especially in children under the age of 2.”
“This voluntary action by McNeil Consumer Healthcare is based on the company’s long-standing commitment to the appropriate use of medications by parents and physicians,” stated Ashley McEvoy, president of McNeil Consumer Healthcare early Thursday morning. “McNeil Consumer Healthcare is committed to providing parents with safe and effective over-the-counter medications that treat their child’s cough-and-cold symptoms. In addition to taking this voluntary action, McNeil Consumer Healthcare, along with our industry partners, supports the Consumer Healthcare Products Association recommendations that were recently submitted to the Food and Drug Administration. These recommendations include label changes to OTC cough-and-cold medicines advising ‘do not use’ in children under 2 years of age. Our voluntary action in removing [these] products from the market is consistent with these recommendations.”